{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-017037","form_type":"8-K","ticker":"HEPA","cik":"0001583771","company_name":"Hepion Pharmaceuticals, Inc.","filed_at":"2025-06-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.882667+00:00","generated_at":"2026-05-18T12:49:15.412063+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Hepion Pharmaceuticals CFO John Brancaccio resigns; interim CFO named","bullets":["John Brancaccio resigned as CFO and director effective June 30, 2025, for personal reasons.","Kaouthar Lbiati assumes role of Interim Chief Financial Officer as of the filing date.","No permanent successor has been announced; company is a clinical-stage biotech (HEPA)."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-017037","json":"https://secwatch.observer/filing/0001641172-25-017037.json","markdown":"https://secwatch.observer/filing/0001641172-25-017037.md","text":"https://secwatch.observer/filing/0001641172-25-017037.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583771/000164117225017037/0001641172-25-017037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583771/000164117225017037/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T12:49:15.412063+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}